ProQR Therapeutics N.V. (NASDAQ:PRQR) announced today the closing of its initial public offering of 8,625,000 ordinary shares at a public offering price of $13.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,125,000 additional ordinary shares. The aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, will be approximately $102 … Continue reading Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN